CELL TECH (HOLDINGS) LIMITED

Company Registration Number:
08802906 (England and Wales)

Unaudited abridged accounts for the year ended 31 December 2024

Period of accounts

Start date: 01 January 2024

End date: 31 December 2024

CELL TECH (HOLDINGS) LIMITED

Contents of the Financial Statements

for the Period Ended 31 December 2024

Balance sheet
Notes

CELL TECH (HOLDINGS) LIMITED

Balance sheet

As at 31 December 2024


Notes
2024
2023


£
£
Fixed assets
Tangible assets: 3 18,541 23,300
Investments: 4 5,686,343 6,181,843
Total fixed assets: 5,704,884 6,205,143
Current assets
Debtors: 5 9,799 24,885
Cash at bank and in hand: 87,890 54,749
Total current assets: 97,689 79,634
Creditors: amounts falling due within one year: 6 (2,348,663) (2,403,968)
Net current assets (liabilities): (2,250,974) (2,324,334)
Total assets less current liabilities: 3,453,910 3,880,809
Creditors: amounts falling due after more than one year: 7 (709,233) (1,195,492)
Provision for liabilities: (150,791) (158,279)
Total net assets (liabilities): 2,593,886 2,527,038
Capital and reserves
Called up share capital: 1,500,000 1,500,000
Profit and loss account: 1,093,886 1,027,038
Shareholders funds: 2,593,886 2,527,038

The notes form part of these financial statements

CELL TECH (HOLDINGS) LIMITED

Balance sheet statements

For the year ending 31 December 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 26 September 2025
and signed on behalf of the board by:

Name: T Sharrock
Status: Director

The notes form part of these financial statements

CELL TECH (HOLDINGS) LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2024

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

Turnover policy

Turnover is recognised at the fair value of the consideration received or receivable for rental income due prior to the Balance Sheet date and provided in the normal course of business, and is shown net of VAT and other sales related taxes.

Tangible fixed assets and depreciation policy

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses. Depreciation is recognised so as to write off the cost or valuation of assets less their estimated residual values over their useful lives on the following bases: Plant and machinery – 20% per annum reducing balance basis Fixtures, fittings and equipment – 25% per annum reducing balance basis

Valuation and information policy

Investment property, which is property held to earn rentals and/or capital appreciation, is initially recognised at cost, which includes the purchase cost and any directly attributable expenditure. Subsequently, it is measured at fair value at the reporting end date. The surplus or deficit on revaluation is recognised in profit or loss.

Other accounting policies

The company has taken advantage of the exemption under section 399 of the Companies Act 2006 not to prepare consolidated accounts, on the basis that the group of which this is the parent qualifies as a small group. The financial statements present information about the company as an individual entity and not about its group.

CELL TECH (HOLDINGS) LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2024

2. Employees

2024 2023
Average number of employees during the period 0 0

CELL TECH (HOLDINGS) LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2024

3. Tangible Assets

Total
Cost £
At 01 January 2024 56,465
At 31 December 2024 56,465
Depreciation
At 01 January 2024 33,165
Charge for year 4,759
At 31 December 2024 37,924
Net book value
At 31 December 2024 18,541
At 31 December 2023 23,300

CELL TECH (HOLDINGS) LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2024

4. Fixed investments

At the Balance Sheet date, investment properties are stated at a fair value of £4,152,843 (2023 - £4,682,843). At the Balance Sheet date, other investments are stated at a fair value of £1,533,500 (2023 - £1,499,000).

CELL TECH (HOLDINGS) LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2024

5. Debtors

2024 2023
££
Debtors due after more than one year: 0 0

CELL TECH (HOLDINGS) LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2024

6. Creditors: amounts falling due within one year note

The aggregate amount of creditors for which security has been given amounted to £19,000 (2023 - £24,241).

CELL TECH (HOLDINGS) LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2024

7. Creditors: amounts falling due after more than one year note

The aggregate amount of creditors for which security has been given amounted to £709,233 (2023 - £1,195,492).